Subsequently, mice bearing subcutaneous CT26-EphA2 tumors were administered anti-EphA2-IR700 alone or followed by 690 nm illumination of the tumor 24 h later (photoimmunotherapy treatment). This evidence concerns the gene DDX53 and neoplasm.